As Celiac and Gluten Sensitivities Gain Prominence, Drug Companies Race to Find Treatments

On behalf of our patient community, CDF has either directly invested or fought to secure investments in diagnostics, research, and treatment for celiac disease.  We have always known that this was a serious disease with broad and often devastating impacts if left undiagnosed and/or untreated.  Our 25 years of hard work continues to yield returns.    This is from a NY Times article published on April 29, 2015, “Pharmaceutical companies are racing to develop the first drugs for celiac disease, which researchers say is much more common than previously thought.”  Read more here